Innate glycosidic activity in metallic implants for localized synthesis of antibacterial drugs
Author(s) -
M. ter Meer,
Ross Dillion,
Signe Maria Nielsen,
Raoul Walther,
Rikke Louise Meyer,
Willeke F. Daamen,
Lambertus P. van den Heuvel,
J. Adam van der Vliet,
Roger M. L. M. Lomme,
Yvonne L. Hoogeveen,
Leo J. Schultze Kool,
Jeremy E. Schaffer,
Alexander N. Zelikin
Publication year - 2018
Publication title -
chemical communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.837
H-Index - 333
eISSN - 1364-548X
pISSN - 1359-7345
DOI - 10.1039/c8cc08737g
Subject(s) - glycosidic bond , prodrug , antibacterial activity , combinatorial chemistry , metal , chemistry , nanotechnology , materials science , bacteria , organic chemistry , biochemistry , biology , genetics , enzyme
Iron-containing metallic implants are shown herein to mediate hydrolysis of glycosidic linkages. Using glucuronide prodrugs for broad-spectrum fluoroquinolone antibacterial agents, we capitalize on this behaviour and perform localized synthesis of antimicrobials which affords a significant zone of inhibition of bacterial growth around the metallic material.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom